The Discounted Cash Flow (DCF) valuation of Boston Scientific Corp (BSX) is 70.33 USD. With the latest stock price at 103.64 USD, the upside of Boston Scientific Corp based on DCF is -32.1%.
Based on the latest price of 103.64 USD and our DCF valuation, Boston Scientific Corp (BSX) is a sell. selling BSX stocks now will result in a potential gain of 32.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.6% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 42.46 - 184.11 | 70.33 |
| Upside | -59.0% - 77.6% | -32.1% |